WallStreetZenWallStreetZen

NASDAQ: TRIB
Trinity Biotech PLC Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

TRIB past revenue growth

How has TRIB's revenue growth performed historically?
Company
-9.1%
Industry
0.14%
Market
16.96%
TRIB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TRIB's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TRIB's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TRIB earnings and revenue history

Current Revenue
$56.8M
Current Earnings
-$24.0M
Current Profit Margin
-42.3%

TRIB Return on Equity

Current Company
N/A
Current Industry
-24%
Current Market
188%

Be the first to know when TRIB announces earnings.

TRIB Return on Assets

Current Company
-33.6%
Current Industry
6.7%
TRIB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TRIB Return on Capital Employed

Current Company
-29.33%
Current Industry
11.6%
TRIB's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TRIB vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TRIB$56.83MN/A-$24.02M-10.15%N/A
STRR$45.79M$26.87M$23.22M-15.16%+34.19%
CHEK$0.00-$19.08M-$17.62MN/AN/A
PMD$22.10M-$768.00k-$4.15M-12.33%N/A
TTOO$7.19M-$42.53M-$50.08M-7.29%N/A
View Top Diagnostic & Research Stocks

Trinity Biotech Earnings & Revenue FAQ

What were TRIB's earnings last quarter?

On Invalid Date, Trinity Biotech (NASDAQ: TRIB) reported Q4 2023 earnings per share (EPS) of N/A, up N/A year over year. Total Trinity Biotech earnings for the quarter were -$5.50 million. In the same quarter last year, Trinity Biotech's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Trinity Biotech stock.

What was TRIB's earnings growth in the past year?

As of Q2 2024, Trinity Biotech's earnings has grown year over year. Trinity Biotech's earnings in the past year totalled -$24.02 million.

What was TRIB's revenue last quarter?

On Invalid Date, Trinity Biotech (NASDAQ: TRIB) reported Q4 2023 revenue of $13.43 million up 14.61% year over year. In the same quarter last year, Trinity Biotech's revenue was $15.73 million.

What was TRIB's revenue growth in the past year?

As of Q2 2024, Trinity Biotech's revenue has grown -9.1% year over year. This is 9.24 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 0.14%. Trinity Biotech's revenue in the past year totalled $56.83 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.